Drug General Information (ID: DDIVI47WPL)
  Drug Name Protriptyline Drug Info Bepridil Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antidepressants Antiarrhythmic Agents
  Structure

 Mechanism of Protriptyline-Bepridil Interaction (Severity Level: Major)
     Increased risk of prolong QT interval Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Protriptyline Bepridil
      Mechanism Prolong QT interval Prolong QT interval
      Key Mechanism Factor 1
Factor Name QT interval
Factor Description Long QT syndrome is a heart signaling disorder that can cause a fast, chaotic heartbeat (arrhythmia). Many people may not exhibit symptoms, and usually the condition is detected during routine medical tests. In others, the most common symptoms include: sudden fainting, palpitations, dizziness, seizures, sudden death.
      Mechanism Description
  • Increased risk of prolong QT interval by the combination of Protriptyline and Bepridil 

Recommended Action
      Management The manufacturer considers the concurrent use of other QT interval-prolonging drugs contraindicated with bepridil.

References
1 Hollingshead LM, Faulds D, Fitton A "Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris." Drugs 44 (1992): 835-57. [PMID: 1280569]
2 Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.